These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 29445162)
21. Druggable epigenetic suppression of interferon-induced chemokine expression linked to Seier JA; Reinhardt J; Saraf K; Ng SS; Layer JP; Corvino D; Althoff K; Giordano FA; Schramm A; Fischer M; Hölzel M J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016720 [TBL] [Abstract][Full Text] [Related]
22. Catastrophic ATP loss underlies a metabolic combination therapy tailored for Dalton KM; Lochmann TL; Floros KV; Calbert ML; Kurupi R; Stein GT; McClanaghan J; Murchie E; Egan RK; Greninger P; Dozmorov M; Ramamoorthy S; Puchalapalli M; Hu B; Shock L; Koblinski J; Glod J; Boikos SA; Benes CH; Faber AC Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33762304 [No Abstract] [Full Text] [Related]
23. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration. Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367 [TBL] [Abstract][Full Text] [Related]
24. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN. Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116 [TBL] [Abstract][Full Text] [Related]
25. Venetoclax-based Rational Combinations are Effective in Models of Dalton KM; Krytska K; Lochmann TL; Sano R; Casey C; D'Aulerio A; Khan QA; Crowther GS; Coon C; Cai J; Jacob S; Kurupi R; Hu B; Dozmorov M; Greninger P; Souers AJ; Benes CH; Mossé YP; Faber AC Mol Cancer Ther; 2021 Aug; 20(8):1400-1411. PubMed ID: 34088831 [TBL] [Abstract][Full Text] [Related]
26. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2. Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759 [TBL] [Abstract][Full Text] [Related]
27. The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner. Mazar J; Gordon C; Naga V; Westmoreland TJ Anticancer Agents Med Chem; 2020; 20(13):1613-1625. PubMed ID: 32329693 [TBL] [Abstract][Full Text] [Related]
34. Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma. Dasgupta A; Alvarado CS; Xu Z; Findley HW Biochem Biophys Res Commun; 2010 Sep; 400(1):53-9. PubMed ID: 20691667 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration. Duijkers FA; Meijerink JP; Pieters R; van Noesel MM Gene; 2013 May; 521(1):62-8. PubMed ID: 23523856 [TBL] [Abstract][Full Text] [Related]
36. Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity. Alptekin A; Ye B; Yu Y; Poole CJ; van Riggelen J; Zha Y; Ding HF Oncogene; 2019 Dec; 38(50):7504-7520. PubMed ID: 31444411 [TBL] [Abstract][Full Text] [Related]
37. SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells. Murakami-Tonami Y; Ikeda H; Yamagishi R; Inayoshi M; Inagaki S; Kishida S; Komata Y; Jan Koster ; Takeuchi I; Kondo Y; Maeda T; Sekido Y; Murakami H; Kadomatsu K Sci Rep; 2016 Aug; 6():31615. PubMed ID: 27539729 [TBL] [Abstract][Full Text] [Related]
38. MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in Feriancikova B; Feglarova T; Krskova L; Eckschlager T; Vicha A; Hrabeta J Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806217 [TBL] [Abstract][Full Text] [Related]
39. GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma. Dong Z; Yeo KS; Lopez G; Zhang C; Dankert Eggum EN; Rokita JL; Ung CY; Levee TM; Her ZP; Howe CJ; Hou X; van Ree JH; Li S; He S; Tao T; Fritchie K; Torres-Mora J; Lehman JS; Meves A; Razidlo GL; Rathi KS; Weroha SJ; Look AT; van Deursen JM; Li H; Westendorf JJ; Maris JM; Zhu S Cancer Res; 2021 Jun; 81(11):2995-3007. PubMed ID: 33602789 [TBL] [Abstract][Full Text] [Related]